These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Administration of activated charcoal or sodium polystyrene sulfonate (Kayexalate) as gastric decontamination for lithium intoxication: an animal model. Linakis JG; Lacouture PG; Eisenberg MS; Maher TJ; Lewander WJ; Driscoll JL; Woolf AD Pharmacol Toxicol; 1989 Nov; 65(5):387-9. PubMed ID: 2622869 [TBL] [Abstract][Full Text] [Related]
8. Lithium absorption prevented by sodium polystyrene sulfonate in volunteers. Tomaszewski C; Musso C; Pearson JR; Kulig K; Marx JA Ann Emerg Med; 1992 Nov; 21(11):1308-11. PubMed ID: 1416323 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of Sodium Polystyrene Sulfonate Dosing Strategies in the Inpatient Management of Hyperkalemia. Mistry M; Shea A; Giguère P; Nguyen ML Ann Pharmacother; 2016 Jun; 50(6):455-62. PubMed ID: 27048188 [TBL] [Abstract][Full Text] [Related]
10. Successful treatment of lithium toxicity with sodium polystyrene sulfonate: a retrospective cohort study. Ghannoum M; Lavergne V; Yue CS; Ayoub P; Perreault MM; Roy L Clin Toxicol (Phila); 2010 Jan; 48(1):34-41. PubMed ID: 19842945 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the tolerability and efficacy of sodium polystyrene sulfonate for long-term management of hyperkalemia in patients with chronic kidney disease. Georgianos PI; Liampas I; Kyriakou A; Vaios V; Raptis V; Savvidis N; Sioulis A; Liakopoulos V; Balaskas EV; Zebekakis PE Int Urol Nephrol; 2017 Dec; 49(12):2217-2221. PubMed ID: 29027620 [TBL] [Abstract][Full Text] [Related]
12. Pretreatment of formula or expressed breast milk with sodium polystyrene sulfonate (Kayexalate(®)) as a treatment for hyperkalemia in infants with acute or chronic renal insufficiency. Thompson K; Flynn J; Okamura D; Zhou L J Ren Nutr; 2013 Sep; 23(5):333-9. PubMed ID: 23707305 [TBL] [Abstract][Full Text] [Related]
13. Effect of sodium polystyrene sulfonate on lithium bioavailability. Bélanger DR; Tierney MG; Dickinson G Ann Emerg Med; 1992 Nov; 21(11):1312-5. PubMed ID: 1416324 [TBL] [Abstract][Full Text] [Related]
14. Treatment of pediatric hyperkalemia with sodium polystyrene sulfonate. Lee J; Moffett BS Pediatr Nephrol; 2016 Nov; 31(11):2113-7. PubMed ID: 27215929 [TBL] [Abstract][Full Text] [Related]
15. Sodium polystyrene sulfonate for the treatment of acute hyperkalemia: a retrospective study. Hagan AE; Farrington CA; Wall GC; Belz MM Clin Nephrol; 2016 Jan; 85(1):38-43. PubMed ID: 26587776 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness of Sodium Polystyrene Sulfonate for Short-Term Treatment of Hyperkalemia. Batterink J; Lin J; Au-Yeung SH; Cessford T Can J Hosp Pharm; 2015; 68(4):296-303. PubMed ID: 26327703 [TBL] [Abstract][Full Text] [Related]
17. In vitro binding of lithium using the cation exchange resin sodium polystyrene sulfonate. Watling SM; Gehrke JC; Gehrke CW; Zumwalt R; Pribble J Am J Emerg Med; 1995 May; 13(3):294-6. PubMed ID: 7755820 [TBL] [Abstract][Full Text] [Related]
18. The use of sodium polystyrene sulfonate in the inpatient management of hyperkalemia. Kessler C; Ng J; Valdez K; Xie H; Geiger B J Hosp Med; 2011 Mar; 6(3):136-40. PubMed ID: 21387549 [TBL] [Abstract][Full Text] [Related]
19. Colon Necrosis Due to Sodium Polystyrene Sulfonate with and without Sorbitol: An Experimental Study in Rats. Ayoub I; Oh MS; Gupta R; McFarlane M; Babinska A; Salifu MO PLoS One; 2015; 10(9):e0137636. PubMed ID: 26413782 [TBL] [Abstract][Full Text] [Related]
20. Damned if you do, damned if you don't: potassium binding resins in hyperkalemia. Watson M; Abbott KC; Yuan CM Clin J Am Soc Nephrol; 2010 Oct; 5(10):1723-6. PubMed ID: 20798253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]